5 Key Takeaways

• 1

  US cancer mortality declined through 2023, largely due to progress against lung cancer.

• 2

  Lung cancer mortality decreased 52% among males and 37% among females from 2004 to 2023.

• 3

  Lung cancer incidence declined by 38% among males and 15% among females from 2003 to 2022.

• 4

  Five-year relative survival for lung cancer doubled from 15% in 2000 to 30% in 2018.

• 5

  Overall cancer incidence increased among females, while remaining stable among males during 2018 to 2022.